Aranesp 100 MCG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FNNQU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,120
Award facts
- Contract value 100% obligated
- $17,119.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aranesp 100 mcg/0.5 ml syringes, with a ceiling value of $17,119.62 under a firm fixed price arrangement. The contract, which was competitively awarded without set-aside designation, has an ultimate completion date of October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Aranesp is an erythropoiesis-stimulating agent used primarily in the treatment of anemia associated with chronic kidney disease and chemotherapy, making this a specialized pharmaceutical supply critical to military and federal healthcare operations.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As one of the major pharmaceutical distributors serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio of competitively awarded delivery orders across multiple therapeutic domains, demonstrating the company's capability to fulfill specialized federal medical supply requirements through flexible contract mechanisms.
Quick answers
Who was awarded contract SPE2DB26FNNQU?
SPE2DB26FNNQU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FNNQU worth?
The government has obligated $17,120 on SPE2DB26FNNQU.
Is contract SPE2DB26FNNQU an order under another contract?
Yes. SPE2DB26FNNQU is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB26FNNQU competed?
The extent of competition for SPE2DB26FNNQU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award